Evidence map›Paper›PMID 39335054›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Evaluation of Biotechnological Active Peptides Secreted by

Elisabete Muchagato Maurício, Patrícia Branco, Ana Luiza Barros Araújo, Catarina Roma-Rodrigues, Katelene Lima, Maria Paula Duarte, Alexandra R Fernandes, Helena Albergaria

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Metabolic engineering ofSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Multi-Kingdom Synergy ofLife (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elisabete Muchagato MaurícioBIORG-Bioengineering and Sustainability Research Group, Faculdade de Engenharia, Universidade Lusófona, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-3959-2993
Patrícia BrancoBIORG-Bioengineering and Sustainability Research Group, Faculdade de Engenharia, Universidade Lusófona, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-1760-6899
Ana Luiza Barros AraújoBIORG-Bioengineering and Sustainability Research Group, Faculdade de Engenharia, Universidade Lusófona, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.
Catarina Roma-RodriguesUCIBIO-Applied Molecular Biosciences Unit, Department Ciências da Vida, NOVA School of Science and Technology, 2829-516 Caparica, Portugal.ORCID 0000-0002-8676-6562
Katelene LimaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-1424-7229
Maria Paula DuarteThe Mechanical Engineering and Resource Sustainability Center (MEtRICs), Chemistry Department, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal.
Alexandra R FernandesUCIBIO-Applied Molecular Biosciences Unit, Department Ciências da Vida, NOVA School of Science and Technology, 2829-516 Caparica, Portugal.ORCID 0000-0003-2054-4438
Helena AlbergariaUnit of Bioenergy and Biorefinary, Laboratório Nacional de Energia e Geologia (LNEG), Estrada do Paço do Lumiar, 22, 1649-038 Lisbon, Portugal.ORCID 0000-0002-9062-9827

Funding

Fundação para a Ciência e Tecnologia PTDC/BII-BIO/31761/2017; UIDP/04378/2020; UIDB/04378/2020; SFRH/BPD/124612/2016;UIDB/04077/2020
6 · The paper itself

Abstract

Biotechnological active peptides are gaining interest in the cosmetics industry due to their antimicrobial, anti-inflammatory, antioxidant, and anti-collagenase (ACE) effects, as well as wound healing properties, making them suitable for cosmetic formulations. The antimicrobial activity of peptides (2-10 kDa) secreted by

Indexed as

anti-ageinganti-collagenaseanti-inflammatoryantimicrobial peptidesbiopreservativesbiotechnological active peptidesSaccharomyces cerevisiae

Identifiers

PMID39335054
PMCPMC11429205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.